Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38507997)

  • 1. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
    Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
    Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics.
    Yousuf M; Sridharan K; Mishra T; Mahadik NS; Banerjee R; Adhikari SS
    Bioorg Chem; 2023 Apr; 133():106395. PubMed ID: 36753964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.
    Pal A; Ganguly A; Ghosh A; Yousuf M; Rathore B; Banerjee R; Adhikari S
    ChemMedChem; 2014 Apr; 9(4):727-32. PubMed ID: 24482362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.
    Sridharan K; Rathore B; Yousuf M; Reddy Rachamalla HK; Jinka S; Jaggarapu MMCS; Banerjee R
    Mol Pharm; 2021 Mar; 18(3):1208-1228. PubMed ID: 33371687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies.
    Abd El-Wahab HAA; Mansour HS; Ali AM; El-Awady R; Aboul-Fadl T
    Bioorg Chem; 2022 Mar; 120():105622. PubMed ID: 35091290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma.
    Ganguly A; Rachamalla HKR; Bhattacharya D; Bhamidipati K; Pal A; Gora Ravuri H; Chakravarty S; Adhikari SS; Banerjee R
    J Drug Target; 2018; 26(5-6):481-493. PubMed ID: 29376759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of New
    Farghaly TA; Pashameah RA; Bayazeed A; Al-Soliemy AM; Alsaedi AMR; Harras MF
    Med Chem; 2024; 20(1):63-77. PubMed ID: 37723960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective
    Abo-Salem HM; Nassrallah A; Soliman AAF; Ebied MS; Elawady ME; Abdelhamid SA; El-Sawy ER; Al-Sheikh YA; Aboul-Soud MAM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32138244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirotriazoline oxindoles: A novel chemical scaffold with in vitro anticancer properties.
    Ribeiro CJA; Nunes RC; Amaral JD; Gonçalves LM; Rodrigues CMP; Moreira R; Santos MMM
    Eur J Med Chem; 2017 Nov; 140():494-509. PubMed ID: 28987608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
    Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
    Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
    Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
    Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
    Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of in vitro cytotoxic effects of triazol/spiroindolinequinazolinedione, triazol/indolin-3-thiosemicarbazone and triazol/thiazol-indolin-2-one conjugates.
    Nazari S; Safari F; Mamaghani MB; Bazgir A
    Daru; 2020 Dec; 28(2):591-601. PubMed ID: 32803690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.
    Dey SK; Bose D; Hazra A; Naskar S; Nandy A; Munda RN; Das S; Chatterjee N; Mondal NB; Banerjee S; Saha KD
    PLoS One; 2013; 8(3):e58055. PubMed ID: 23472133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel spiropyrazoline oxindoles and evaluation of cytotoxicity in cancer cell lines.
    Monteiro Â; Gonçalves LM; Santos MM
    Eur J Med Chem; 2014 May; 79():266-72. PubMed ID: 24747063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.
    Pathak A; Pandey V; Raj Pokharel Y; Devaraji V; Ali A; Haider K; Saad S; Dewangan RP; Siddiqui N; Shahar Yar M
    Bioorg Chem; 2021 Nov; 116():105358. PubMed ID: 34544029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
    Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
    Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
    Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity.
    Ragab MA; Elagawany M; Daabees H; Ahmed AF; Awad EM; Billon C; Elgendy B; Abouzid KAM; Kassab SE
    Bioorg Chem; 2022 Feb; 119():105554. PubMed ID: 34923243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.